Benjamin S. Daniel
YOU?
Author Swipe
View article: Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies
Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies Open
Actinic prurigo (AP) is a rare, idiopathic, acquired photodermatosis predominantly affecting indigenous populations in North, Central and South America. It is characterised by intensely pruritic papules and nodules on sun‐exposed skin, wit…
View article: Pilot Study of Tildrakizumab in the Treatment of Stable Non‐Segmental Vitiligo
Pilot Study of Tildrakizumab in the Treatment of Stable Non‐Segmental Vitiligo Open
Background Treatment for vitiligo is limited, with variable efficacy, and can be time‐consuming or expensive. Recent developments within biologic therapy have demonstrated promising results with managing chronic autoimmune conditions. Obje…
View article: Psychosocial Determinants and Atopic Dermatitis Outcomes: A Cross‐Sectional Study From an Australian Paediatric Centre
Psychosocial Determinants and Atopic Dermatitis Outcomes: A Cross‐Sectional Study From an Australian Paediatric Centre Open
Background Atopic dermatitis (AD) significantly impacts quality of life, with well‐documented physical and psychological consequences. While disease burden is well characterised, the influence of psychosocial determinants on AD outcomes re…
View article: Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review Open
Vaccination plays a critical role in protecting against infectious diseases, particularly in those with compromised immune systems. While traditional recommendations advise against live attenuated vaccination in patients undergoing most bi…
View article: A narrative review of the literature: The role of biologics and <scp>JAK</scp> inhibitors in vitiligo
A narrative review of the literature: The role of biologics and <span>JAK</span> inhibitors in vitiligo Open
Vitiligo is a chronic depigmenting disorder that significantly impacts the quality of life of patients. Though there have been significant advancements in targeted therapies in skin diseases such as psoriasis or eczema, the progress in the…
View article: A review of <scp>JAK</scp> and <scp>IL</scp>‐23 inhibitors to treat vitiligo
A review of <span>JAK</span> and <span>IL</span>‐23 inhibitors to treat vitiligo Open
Vitiligo is an autoimmune skin disorder resulting in the depigmentation of skin characterised by patches of varying sizes and shapes. A common disorder of pigmentation that affects 0.5%–2% of the global population. Despite its well‐underst…
View article: Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemic
Use of a hybrid teledermatology model in an Australian tertiary hospital during the COVID-19 pandemic Open
To the Editor: The COVID-19 pandemic has led to the adoption of teledermatology by health services across the world. There is increasing support for the use of teledermatology in the outpatient setting; however, its role in inpatient and e…
View article: Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospital
Pityriasis rubra pilaris treatment options: A retrospective case series from a tertiary hospital Open
Pityriasis rubra pilaris (PRP) is a group of uncommon chronic inflammatory skin conditions with unclear pathophysiology and etiology. To date there is limited published literature and no clinical guidelines for the management of PRP. Infli…
View article: Impact of COVID‐19 on inpatient dermatology consults in an Australian tertiary hospital
Impact of COVID‐19 on inpatient dermatology consults in an Australian tertiary hospital Open
The first case of COVID-19 was identified in December 2019 with progression to the declaration of a worldwide pandemic announced in March 2020 by the World Health Organisation. It has had an impact on medical practice and patient behaviour…
View article: Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts Open
Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled…
View article: Infliximab drug survival in chronic plaque psoriasis: follow‐up of the product familiarisation program
Infliximab drug survival in chronic plaque psoriasis: follow‐up of the product familiarisation program Open
Infliximab drug survival in chronic plaque psoriasis: follow up of the product familiarisation program
View article: Cutaneous lupus erythematosus: A review of the literature
Cutaneous lupus erythematosus: A review of the literature Open
Knowledge with regard to the pathogenesis of lupus erythematosus has progressed rapidly over the past decade, and with it has come promising new agents for the treatment of cutaneous lupus erythematous (CLE). Classification of CLE is perfo…
View article: Electroporation of Vibrio natriegens (Weinstock et al. 2016, modified .) v1
Electroporation of Vibrio natriegens (Weinstock et al. 2016, modified .) v1 Open
A protocoll outlining the Preperation and transformation of electro-competent cells for Vibrio natriegens Preparation of electrocompetent cells (Vibrio natrigens) 10 mL BHI (Brain haert infusion) + v2 salts Overnight culture Inoculation of…